An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-02-03
DOI
https://doi.org/10.3389/fimmu.2025.1546794
Citations
3
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis

Jun Hao, Li Ma, Xiaolu Yang, Bei He et al.
3 citations
Frontiers in Immunology
Ferroptosis and cancer prognosis
4.56
article

An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis

Jun Hao, Li Ma, Xiaolu Yang, Bei He, Shiyu Zhang, Chang Yuan, Xiaolong Li, Tianqi Zhang, Cuizhi Geng, Yilun Li, Yunjiang Liu, Yaqi Peng
article en
3 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Hebei University of Engineering (CN), Hebei Medical University (CN), Fourth Hospital of Hebei Medical University (CN), Xingtai People's Hospital (CN), Affiliated Hospital of Hebei University (CN)
Good health and well-being
Openalex Percentile: Top 7%
Ferroptosis and cancer prognosis
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.